Tom Lawlor receives two-year suspension from USADA

Tom Lawlor receives two-year suspension from USADA

While the news came yesterday that UFC’s Gian Villante was granted a therapeutic use exemption (TUE), which cleared him of a failed USADA test, it was later announced that Tom Lawlor was not so lucky.

USADA announced yesterday that Lawlor has been served a two-year suspension for a failed out-of-competition test conducted on October 10, 2016.

According to the USADA press release:

“Lawlor, 33, tested positive for ostarine following an out-of-competition urine test conducted on October 10, 2016. Ostarine is a prohibited substance in the category of Anabolic Agents and is prohibited at all times under the UFC Anti-Doping Policy, which has adopted the WADA Prohibited List.

Ostarine, also known as MK-2866 and Enobosarm, is a non-FDA approved selective androgen receptor modulator (SARM) which is illegally sold in the United States and globally as a performance-enhancing substance. Ostarine is not currently available as a prescription medication in any country, and its unauthorized use may carry serious side effects. Nonetheless, ostarine has been found as a declared and undeclared ingredient in many dietary supplements sold in the United States, which has prompted the U. S. Food and Drug Administration (FDA) to issue warning letters to specific dietary supplement manufacturers stating that ostarine is an unapproved new drug and that selling the drug is in violation of the Federal Food, Drug, and Cosmetic Act (FDCA).”

In early 2016, Tim Means failed a drug test for ostarine as well, but it was determined by USADA to have most likely come from a tainted supplement, and thus gave him a reduced suspension of 6 months as opposed to the full two years.

Lawlor (10-6, 1NC) last fought in March of 2016 at UFC 196 where he suffered a unanimous decision loss to Corey Anderson. His suspension is retroactive to October 10, 2016.